NO20072633L - Kjemisk prosess - Google Patents
Kjemisk prosessInfo
- Publication number
- NO20072633L NO20072633L NO20072633A NO20072633A NO20072633L NO 20072633 L NO20072633 L NO 20072633L NO 20072633 A NO20072633 A NO 20072633A NO 20072633 A NO20072633 A NO 20072633A NO 20072633 L NO20072633 L NO 20072633L
- Authority
- NO
- Norway
- Prior art keywords
- processes
- chemical process
- dyslipidemias
- manifestations
- enzymatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P11/00—Preparation of sulfur-containing organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/52—Propionic acid; Butyric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Enzymatiske og kjemiske fremgangsmåter og prosesser for fremstilling av visse av 3-fenyl-2-arylalkyltiopropionsyrederivater som er anvendelige i behandling av kliniske tilstander omfattende lipidlidelser (dyslipidemier) hvorvidt eller ikke forbundet med insulinresistens og andre manifestasjoner av det metabolske syndrom er beskrevet og også visse nye mellomprodukter anvendt i disse prosesser.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0427524.4A GB0427524D0 (en) | 2004-12-16 | 2004-12-16 | Chemical process |
PCT/GB2005/004800 WO2006064213A2 (en) | 2004-12-16 | 2005-12-14 | Chemical process |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072633L true NO20072633L (no) | 2007-06-21 |
Family
ID=34090119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072633A NO20072633L (no) | 2004-12-16 | 2007-05-24 | Kjemisk prosess |
Country Status (17)
Country | Link |
---|---|
US (1) | US7803586B2 (no) |
EP (1) | EP1828394A2 (no) |
JP (1) | JP2008523797A (no) |
KR (1) | KR20070094908A (no) |
CN (1) | CN101080495A (no) |
AR (1) | AR052054A1 (no) |
AU (1) | AU2005315454A1 (no) |
BR (1) | BRPI0518948A2 (no) |
CA (1) | CA2588591A1 (no) |
GB (1) | GB0427524D0 (no) |
IL (1) | IL183524A0 (no) |
MX (1) | MX2007007219A (no) |
NO (1) | NO20072633L (no) |
SA (1) | SA05260405A (no) |
TW (1) | TW200636071A (no) |
UY (1) | UY29271A1 (no) |
WO (1) | WO2006064213A2 (no) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001011072A1 (en) | 1999-08-05 | 2001-02-15 | Novo Nordisk A/S | Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids |
JP2003506065A (ja) * | 1999-08-05 | 2003-02-18 | ノボ ノルディスク アクティーゼルスカブ | 置換された3−フェニル−プロパン酸エステル及び置換された3−フェニル−プロパン酸の調製の方法 |
SE0104333D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
GB0314131D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314075D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314130D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
GB0314260D0 (en) | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
-
2004
- 2004-12-16 GB GBGB0427524.4A patent/GB0427524D0/en not_active Ceased
-
2005
- 2005-12-14 BR BRPI0518948-9A patent/BRPI0518948A2/pt not_active Application Discontinuation
- 2005-12-14 EP EP05818266A patent/EP1828394A2/en not_active Withdrawn
- 2005-12-14 SA SA05260405A patent/SA05260405A/ar unknown
- 2005-12-14 CN CNA200580043506XA patent/CN101080495A/zh active Pending
- 2005-12-14 CA CA002588591A patent/CA2588591A1/en not_active Abandoned
- 2005-12-14 JP JP2007546171A patent/JP2008523797A/ja active Pending
- 2005-12-14 AU AU2005315454A patent/AU2005315454A1/en not_active Abandoned
- 2005-12-14 MX MX2007007219A patent/MX2007007219A/es not_active Application Discontinuation
- 2005-12-14 KR KR1020077015115A patent/KR20070094908A/ko not_active Application Discontinuation
- 2005-12-14 WO PCT/GB2005/004800 patent/WO2006064213A2/en active Application Filing
- 2005-12-14 US US11/793,134 patent/US7803586B2/en not_active Expired - Fee Related
- 2005-12-16 AR ARP050105310A patent/AR052054A1/es not_active Application Discontinuation
- 2005-12-16 TW TW094144603A patent/TW200636071A/zh unknown
- 2005-12-20 UY UY29271A patent/UY29271A1/es not_active Application Discontinuation
-
2007
- 2007-05-24 NO NO20072633A patent/NO20072633L/no not_active Application Discontinuation
- 2007-05-29 IL IL183524A patent/IL183524A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101080495A (zh) | 2007-11-28 |
AR052054A1 (es) | 2007-02-28 |
MX2007007219A (es) | 2007-08-14 |
GB0427524D0 (en) | 2005-01-19 |
UY29271A1 (es) | 2006-07-31 |
US7803586B2 (en) | 2010-09-28 |
WO2006064213A3 (en) | 2006-08-24 |
JP2008523797A (ja) | 2008-07-10 |
SA05260405A (ar) | 2005-12-03 |
KR20070094908A (ko) | 2007-09-27 |
US20080115247A1 (en) | 2008-05-15 |
TW200636071A (en) | 2006-10-16 |
BRPI0518948A2 (pt) | 2008-12-16 |
AU2005315454A1 (en) | 2006-06-22 |
CA2588591A1 (en) | 2006-06-22 |
EP1828394A2 (en) | 2007-09-05 |
WO2006064213A2 (en) | 2006-06-22 |
IL183524A0 (en) | 2007-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Maugeri et al. | Resveratrol modulates SIRT1 and DNMT functions and restores LINE-1 methylation levels in ARPE-19 cells under oxidative stress and inflammation | |
BRPI1005683A2 (pt) | processo livre de células in vitro de produção de um ácido desoxirribonucleio (dna) linear fechado, kit, método de indução de reação imunológica contra um antígeno em um hospedeiro, processo de elaboração de uma composição farmacêutica e uso de uma molécula de dna linear fechado na fabricação de um medicamento | |
NO20076055L (no) | Imidazo- og triazolopyridiner som inhibitorer av 11-beta-hydroksysteroid-dehydrogenase type I | |
NO20072608L (no) | Biaryloksymetylarenkarboksylsyrer | |
NO20044436L (no) | Substituerte fenyleddiksyrer | |
BRPI0915531A2 (pt) | Composição de enzima de sacarificação e método de sacarificação da mesma | |
NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
NO20091588L (no) | Kjemisk prosess | |
BRPI0512624A (pt) | compostos heteroarila e fenilsulfamoìla substituìdos | |
NO20065535L (no) | Behandling av respiratorisk sykdom | |
CO6640286A2 (es) | Proceso in vitro para la determinacion rapida en un paciente del estado de infeccion con mycrobacterium tuberculosis | |
BR112015005416A2 (pt) | produção de ácidos orgânicos por meio de fermentação em baixo ph | |
BR112012018385A2 (pt) | indução e estabilização de atividade enzimática em micro-organismos | |
AR113180A1 (es) | Procedimiento para la producción de etanol | |
BR112014031934A2 (pt) | método com base em euglobulina para determinar a atividade biológica de defibrotide | |
NO20081082L (no) | Nye piperidinderivater som kjemokinreseptorformulatorer som er nyttige for behandling av respiratoriske sykdommer | |
NO20083751L (no) | Metoder for behandling av kognitive og andre sykdommer | |
Dawadi et al. | Synthesis and analysis of bacterial folate metabolism intermediates and antifolates | |
NO20074639L (no) | Krystallinsk base av trans-1-((1R,3S)-6-klor-3-fenylindan-1-yl)-3,3-dimetylpiperazin | |
Camadan et al. | Purification and characterization of dihydropyrimidine dehydrogenase enzyme from sheep liver and determination of the effects of some anaesthetic and antidepressant drugs on the enzyme activity | |
Sgarbi et al. | Human NARP mitochondrial mutation metabolism corrected with α-ketoglutarate/aspartate: a potential new therapy | |
NO20080034L (no) | Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
WO2006113095A3 (en) | Methods for diagnosing a bipolar disorder and attention-deficit/hyperactivity disorder | |
NO20072633L (no) | Kjemisk prosess | |
NO20090292L (no) | Fenyleddiksyrederivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |